EUVIMEDEUVIMED entdecken
Crossref

Magnetic and pH-responsive magnetite/chitosan (core/shell) nanoparticles for dual-targeted methotrexate delivery in cancer therapy

Ana Medina-Moreno, Mazen M El-Hammadi, Gema I Martínez-Soler, Javier G Ramos, Gracia García-García, José L Arias iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01701-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Ana Medina-Moreno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Granada, 18011, Spain. Hauptthemen laut MEDLINE: Methotrexate, Chitosan, Magnetite Nanoparticles, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Junta de Andalucía (Andalusia, Spain).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate successful therapy encounters various challenges in chemotherapy, such as poor oral bioavailability, low specificity, side effects and the development of drug resistances. In this study, it is proposed a dual-targeted nanocarrier comprising magnetite/chitosan nanoparticles for an efficient Methotrexate delivery. The formation of the particles was confirmed through morphological analysis using electron microscopy and elemental mappings via energy dispersive X-ray spectroscopy. These nanoparticles exhibited a size of ≈ 270 nm, a zeta potential of ≈ 24 mV, and magnetic responsiveness, as demonstrated by hysteresis cycle analysis and visual observations under a magnetic field. In addition, these particles displayed high stability, as evidenced by size and surface electric charge measurements, during storage at both 4 ºC and 25 ºC for at least 30 days. Electrophoretic properties were examined in relation to pH and ionic strength, confirming these core/shell nanostructure. The nanoparticles demonstrated a pH-responsive drug release as observed by a sustained Methotrexate release over the next 90 h under pH ≈ 7.4, while complete release occurred within 3 h under acidic conditions (pH ≈ 5.5). In the biocompatibility assessment, the magnetite/chitosan particles showed excellent hemocompatibility ex vivo and no cytotoxic effects on normal MCF-10 A and cancer MCF-7 cells. Furthermore, the Methotrexate-loaded nanoparticles significantly enhanced the antitumor activity reducing the half-maximal inhibitory concentration by ≈ 2.7-fold less compared to the free chemotherapeutic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateChitosanMagnetite NanoparticlesAntimetabolites, AntineoplasticHydrogen-Ion ConcentrationHumansDrug LiberationAnimalsCell SurvivalDrug Delivery SystemsParticle SizeDrug CarriersMCF-7 Cells

Stichwörter der Autor:innen

Cancer targeted therapyChitosanCore/shell nanoparticleMagnetic-driven nanoparticlesMagnetiteMethotrexatepH-responsive drug release

Substanzen

MethotrexateChitosanMagnetite NanoparticlesAntimetabolites, AntineoplasticDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Granada, 18011, Spain.
  • Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Seville, Sevilla, 41012, Spain.
  • Department of Nursing Sciences, Physiotherapy and Medicine, Faculty of Health Sciences, University of Almería, Almería, 04120, Spain.
  • Biomedical Research Unit, Torrecárdenas University Hospital, Almería, 04009, Spain.
  • Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, Granada, 18011, Spain. jlarias@ugr.es.
  • Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, 18016, Spain. jlarias@ugr.es.

ORCID-Profile: José L Arias

Förderung

  • Instituto de Salud Carlos III
  • Junta de Andalucía (Andalusia, Spain)

Zitieren

APA

Medina-Moreno, A., El-Hammadi, M. M., Martínez-Soler, G. I., Ramos, J. G., García-García, G., & Arias, J. L. (2025). Magnetic and pH-responsive magnetite/chitosan (core/shell) nanoparticles for dual-targeted methotrexate delivery in cancer therapy. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01701-y

Vancouver

Medina-Moreno A, El-Hammadi MM, Martínez-Soler GI, Ramos JG, García-García G, Arias JL. Magnetic and pH-responsive magnetite/chitosan (core/shell) nanoparticles for dual-targeted methotrexate delivery in cancer therapy. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01701-y

BibTeX
@article{MedinaMoreno2025,
  author = {Medina-Moreno, Ana and El-Hammadi, Mazen M and Martínez-Soler, Gema I and Ramos, Javier G and García-García, Gracia and Arias, José L},
  title = {Magnetic and pH-responsive magnetite/chitosan (core/shell) nanoparticles for dual-targeted methotrexate delivery in cancer therapy},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01701-y}
}
Kostenlos starten →